Toggle Main Menu Toggle Search

Open Access padlockePrints

The renal effects of N-10-propargyl-5,8-dideazafolic acid (CB 3717) and a non-nephrotoxic analog ICI D 1694, in mice

Lookup NU author(s): Professor Herbie Newell, Sarah Morgan, Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino] -2-thenoyl)-L-glutamic acid (ICI D1694) is an analogue of the thymidylate synthase inhibitor, N10 -propargyl-5,8-dideazafolic acid (CB3717). CB3717 was found to be active in early clinical studies, but its use was limited by nephrotoxicity. ICI D1694 is a more potent antitumour agent than CB3717 and is also more water soluble. Previous studies have shown ICI D1694 to be non-toxic to the kidney following a single administration but its renal effects after chronic administration are unknown. To assess these effects, and further define the time course and dose relationship of CB3717-induced renal damage, an assay of glomerular filtration rate (GFR) has been developed which can be used in mice and hence in the screening of novel compounds. The 14C-inulin clearance assay developed was used to show a linear relationship between CB3717 dosage and renal damage (r= - 0.989) following a single bolus dose (50-200mgkg-1, in mice. CB3717-induced renal damage is persistent (>6 weeks) and renal scarring was noted. ICI D1694 has been shown to be non-nephrotoxic following weekly administration of 250 mg kg-1 for 6 weeks. Measurement of GFR has been shown to be a more sensitive indicator of impaired renal function than plasma urea and creatinine concentration, and the measurement of plasma creatinine concentration in particular, appears to be without value in the screening of potential nephrotoxins in certain mouse strains.


Publication metadata

Author(s): Jodrell DI, Newell DR, Morgan SE, Clinton S, Bensted JPM, Hughes LR, Calvert AH

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 1991

Volume: 64

Issue: 5

Pages: 833-838

Print publication date: 01/11/1991

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

PubMed id: 92030954


Share